Big companies rarely admit they need a rival. They prefer to rebrand the problem, restructure a division, or roll out a new strategy with a vaguely inspirational name. But every now and then, the math wins. For most of the past 30 years, the German auto industry was the math. It built the cars, set
People wait for things to get cheaper before they buy. That is as human as any instinct gets. We delay the vacation, hold off on the new car, refresh the airline app every morning until the fare seems reasonable. For something as expensive as a home, that waiting instinct doesn’t just linger. It compounds into
Eli Lilly’s first-quarter report gave Wall Street another reason to stay optimistic about one of the market’s biggest pharmaceutical winners, even as analysts continue to weigh how much growth is already priced into the stock. Bank of America reiterated its Buy rating on Eli Lilly and set a $1,133 price objective on the stock, according
For most of 2026, General Motors (GM) has been a stock that makes investors nervous. From tariff headlines, EV restructuring charges, a war in the Middle East pushing up raw material costs, and a share price that’s down year-to-date, even as the one-year return sits at an impressive 70%. Then came the first-quarter earnings report.
If you’re a driver who finds stopping in to your local gas station or even Costco or Walmart painful, you have to be glad April is over. But there’s a problem. The high fuel prices you just suffered through as war raged in the Persian Gulf aren’t going away. You might even see U.S. gas
Kevin O’Leary has spent decades telling entrepreneurs on national television precisely what their businesses are worth. Now he is sharing something he rarely details publicly: the exact way he allocates his own money across asset classes, and why he believes most investors overcomplicate their approach to building wealth. In a recent appearance on The Iced
The bill for a quieter, safer financial system is arriving, and it is bigger than most institutions expected. There is a cost building inside the global financial system that rarely makes headlines on its own but shows up everywhere: in compliance budgets, in licensing timelines, in the engineering hours spent integrating with new regulatory requirements.
Well, no one saw that coming. A hike in interest rates may not be imminent but the tea leaves from this week’s Federal Open Market Committee meeting indicate that surging energy prices from the Iran War is on the radar of some of its 12 members. Scott Pike, senior portfolio manager at Income Research +
Qualcomm Incorporated (QCOM) added roughly $15 billion in market value as investors embraced a story that reaches beyond any handset rebound. The stock jumped 12% on evidence that new growth drivers are moving into measurable execution. The stock still trades with heavy exposure to smartphone cycles, but that’s starting to shift as automotive scales, custom
Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and Goldman Sachs appears to be asking for more proof before getting more bullish on the stock. Goldman Sachs analyst Asad Haider maintained a hold rating on Pfizer and lowered his price target to $26,